AI assistant
Sending…
Cigna Group — Director's Dealing 2025
Mar 17, 2025
29918_dirs_2025-03-17_ae08d3f8-c040-4887-9f8f-0c788accf0aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2025-03-14
Reporting Person: Granger Elder (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-14 | Common Stock, $.01 Par Value | M | 2376.0000 | $151.4786 | Acquired | 7847.0000 | Direct |
| 2025-03-14 | Common Stock, $.01 Par Value | S | 2376.0000 | $310.3500 | Disposed | 5471.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-14 | Employee Stock Option (Right to Buy) | $151.4786 | M | 2376.0000 | Disposed | 2026-05-04 | Common Stock, $.01 Par Value (2376.0000) | Direct |
Footnotes
F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024.
F2: These stock options were granted on May 4, 2016 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018.
More from Cigna Group
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4